venBio Global Strategic Fund II L.P., 10% Owner at Menlo Therapeutics, Inc. (MNLO), bought 1,461,552 shares at $17.00 ($4.5M) on 2018-01-25, disclosed to the SEC on 2018-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 265,000 | $4.5M | 100.0% |
| 2 | $0.00 | 1,196,552 | $0 | 0.0% |
| Total | $3.08 avg | 1,461,552 | $4.5M | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |